Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


The Application of Ketamine for Sedation in Patients With Cardiac Arrest: Feasibility, Safety, and Potential Impact on Neurological Outcomes


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04360070

Organisation Name: Fraser Health

Overal Status: Not yet recruiting

Start Date: August 2020

Last Update: July 7, 2020

Lead Sponsor: Fraser Health

Brief Summary: Recent evidence suggests ketamine may attenuate harmful cellular cascades taking place after brain injury that result in permanent damage. The investigators are interested in researching the application of this in the setting of cardiac arrest. Following cardiac arrest, the brain is deprived oxygen for a period of time, leading to the imitation of these harmful cellular processes. The investigators hypothesize that patients who receive ketamine as part of their standard sedation procedures during cardiac arrest treatment have better neurological functioning compared to those who do not.

Conditions:
  • Cardiac Arrest, Out-Of-Hospital
  • Ketamine
  • Neurologic Manifestations


Total execution time in seconds: 0.14908313751221